Genopathy
Gene-Disorder Association · Article
Gene
SCN4A
Sodium Voltage-Gated Channel Alpha Subunit 4
Disorder
Pain Disorder
Approved treatment annotated
Association Review

In brief

The association between SCN4A (Sodium Voltage-Gated Channel Alpha Subunit 4) and Pain Disorder is supported by expert-curated evidence, drawing on a single expert-curated source, which records likely-pathogenic variants.

Sources 1
Clinical variants 1
Symptoms 0
Compounds 8
Trials 0of 3,308 via SCN4A compounds
Publications 0
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
SCN4A

The gene

2 source summaries

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Pain Disorder

The disorder

4 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
ClinVar and variant evidence

Genetic basis

1 clinical variant

ClinVar variants reported for this pair, with disorder-specific significance, review status, molecular consequence and origin.

Request access
06
Interventions

Therapeutics

8 compounds & drugs

Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.

Request access
07
Human studies

Clinical trials

3,308 clinical trials

Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.

Request access
08
Provenance

References & sources

5 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access